Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | HRMY Harmony Biosciences Holdings, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $41.58 +0.1% | $16.33 -2.0% |
| StockIQ Score | 77B+ Strong Risk: Medium | 35F Weak Risk: High |
| Technical | 94A+ | 13F |
| Fundamental | 83A- | 35F |
| Growth | 70B | 50C- |
| Fair Value | 62C+ | 38F |
| News | 80A- | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 54C- | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
HRMY received a STRONG rating with an investorScore of 77, far above AAPG’s 35 and a WEAK rating. Its technicalScore (94), fundamentalScore (83), growthScore (70) and valuationScore (62) all exceed AAPG’s 13, 35, 50 and 38 respectively. Across every metric HRMY outperforms AAPG.